BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 11865366)

  • 1. Surgical risk model for acute diffuse peritonitis based on a Japanese nationwide database: an initial report on the surgical and 30-day mortality.
    Nakagoe T; Miyata H; Gotoh M; Anazawa T; Baba H; Kimura W; Tomita N; Shimada M; Kitagawa Y; Sugihara K; Mori M
    Surg Today; 2015 Oct; 45(10):1233-43. PubMed ID: 25228380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients.
    Sakamoto Y; Inoue S; Iwamura T; Yamashita T; Nakashima A; Nishimura Y; Koami H; Imahase H; Goto A; Yamada KC; Mashiko K; Yokota H
    Yonsei Med J; 2013 May; 54(3):686-9. PubMed ID: 23549815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staged lavage versus single high-volume lavage in the treatment of feculent/purulent peritonitis: a matched pair analysis.
    Moussavian MR; Richter S; Kollmar O; Schuld J; Schilling MK
    Langenbecks Arch Surg; 2009 Mar; 394(2):215-20. PubMed ID: 19101723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of acupuncture treatment in patients with chronic neck pain.
    Willich SN; Reinhold T; Selim D; Jena S; Brinkhaus B; Witt CM
    Pain; 2006 Nov; 125(1-2):107-13. PubMed ID: 16842918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and outcome of neurosurgical patients requiring ventilatory support after intensive care unit stay.
    Malmivaara K; Hernesniemi J; Salmenperä R; Ohman J; Roine RP; Siironen J
    Neurosurgery; 2009 Sep; 65(3):530-7; discussion 537-8. PubMed ID: 19687698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
    Moubarak P; Zilker S; Wolf H; Hofner B; Kneib T; Küchenhoff H; Jauch KW; Hartl WH
    Shock; 2008 Dec; 30(6):634-41. PubMed ID: 18520701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of activated protein C in real-life clinical practice.
    Dhainaut JF; Payet S; Vallet B; França LR; Annane D; Bollaert PE; Le Tulzo Y; Runge I; Malledant Y; Guidet B; Le Lay K; Launois R;
    Crit Care; 2007; 11(5):R99. PubMed ID: 17822547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and adjuvant therapy in patients with diffuse peritonitis: cost analysis.
    Welcker K; Lederle J; Schorr M; Siebeck M
    World J Surg; 2002 Mar; 26(3):307-13. PubMed ID: 11865366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antithrombin III in inhalation injury.
    Latenser BA
    J Burn Care Res; 2009; 30(1):186-8. PubMed ID: 19060754
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.